Abstract. Functional and structural changes in the mammalian ovary are coordinately regulated by the pituitary glycoprotein hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), leading to follicular development, ovulation and transformation of follicles into corpus lutea. To investigate protein profiles during these processes of the mouse ovarian cycle, we applied combined methods (two-dimensional gel electrophoresis for separation and visualization of proteins plus matrix laser desorption/ionization time-of-flight mass spectrometry [MALDI-TOF/MS] analysis for protein identification) for comparative proteomic analysis using immature mice at 3 weeks of age. Protein profiles were obtained from proteins extracted from intact ovaries that had been collected from pregnant mare serum gonadotropin (PMSG)/human chorionic gonadotropin (hCG)-primed immature mice at 0 (no PMSG), 24 and 48 h post PMSG, as well as at 10 and 20 h post hCG. The results showed that 1028 common protein spots were found in representative gels that had been separated in the 3 to 11 pH range and the 15-200 kDa range, 253 protein spots (24.6%) of which were differentially expressed (p<0.05) during the mouse ovarian cycle. Of these 253 protein spots, 99 were identified by MALDI-TOF/MS. This comparative proteomic approach to identifying proteins that were potentially involved in the complex process of the ovarian cycle could contribute to our understanding of the molecular basis of functional and structural changes in the ovary in response to gonadotropins. Furthermore, the interesting ovarian proteins identified in this study may eventually serve as diagnostic biomarker candidates of ovarian function. Key words: Follicle stimulating hormone, Luteinizing hormone, Ovary, Proteome, Two-dimensional gel electrophoresis (J. Reprod. Dev. 55: [316][317][318][319][320][321][322][323][324][325][326] 2009) omplex biological processes in the mammalian ovary, such as follicular development, oocyte maturation, oocyte meiosis, ovulation and corpus luteum formation and demise, are coordinately regulated by autocrine, paracrine and endocrine factors of the hypothalamic-pituitary-ovarian axis [1] [2] [3] . Specifically, follicle-stimulating hormone (FSH) is a major promoter for orchestrating follicular development and differentiation in the granulosa cells of preovulatory follicles [4] [5] [6] . Luteinizing hormone (LH) plays a key role in initiation of the ovulatory process of preovulatory follicles by activating multiple cellular signaling pathways [5, 7] . Detailed biological changes in gene expression and follicular structure occur due to the overlapping control of FSH and LH, and the theca, granulosa, cumulus and oocyte compartments of the ovarian follicle are interdependently regulated by them. Moreover, the universal and local actions of these gonadotropins are coordinated with signals from the oocyte to promote ovulation under multipartite control, facilitating synchronization of oocyte maturation with follicle rupture and resulting in selection of oocytes with full developmental competence for succession to the reproductive pool. However, the relationship between the expression of specific factors during follicular growth and their ability to determine the selection of oocytes has yet to be investigated. In addition, little is known about the factors that promote follicular growth during the transition of the follicle from the preantral to antral stage, which is most susceptible to follicular atresia [8] .
(J. Reprod. Dev. 55: [316] [317] [318] [319] [320] [321] [322] [323] [324] [325] [326] 2009) omplex biological processes in the mammalian ovary, such as follicular development, oocyte maturation, oocyte meiosis, ovulation and corpus luteum formation and demise, are coordinately regulated by autocrine, paracrine and endocrine factors of the hypothalamic-pituitary-ovarian axis [1] [2] [3] . Specifically, follicle-stimulating hormone (FSH) is a major promoter for orchestrating follicular development and differentiation in the granulosa cells of preovulatory follicles [4] [5] [6] . Luteinizing hormone (LH) plays a key role in initiation of the ovulatory process of preovulatory follicles by activating multiple cellular signaling pathways [5, 7] . Detailed biological changes in gene expression and follicular structure occur due to the overlapping control of FSH and LH, and the theca, granulosa, cumulus and oocyte compartments of the ovarian follicle are interdependently regulated by them. Moreover, the universal and local actions of these gonadotropins are coordinated with signals from the oocyte to promote ovulation under multipartite control, facilitating synchronization of oocyte maturation with follicle rupture and resulting in selection of oocytes with full developmental competence for succession to the reproductive pool. However, the relationship between the expression of specific factors during follicular growth and their ability to determine the selection of oocytes has yet to be investigated. In addition, little is known about the factors that promote follicular growth during the transition of the follicle from the preantral to antral stage, which is most susceptible to follicular atresia [8] .
Understanding of the profiles of the gonadotropin-responsive factors that are involved in the processes of follicular growth and ovulation induced in response to FSH or LH has provided valuable information with regard to identification of biomarkers of follicular growth and/or selection of healthy oocytes. So far, a number of candidate genes with potential importance for ovarian functions have been identified by transcriptomic analysis [9] [10] [11] [12] . One approach to investigating molecular events during the preovulatory and ovulatory phases is to reveal the gene expression profile of ovarian follicular cells by cDNA microarray in response to gonadotropin stimulation. A complementary but less explored approach is study of the protein profile expressed in an ovary during the preovulatory and ovulatory phases. This proteomic analysis can provide a much clearer understanding of posttranscriptional processes such as alternative splicing, translational regulation, posttranslational modifications and protein-protein interactions in signaling cascade or biological pathways [13, 14] .
A large-scale proteomics analysis method has been developed using combinations of two-dimensional gel electrophoresis (2-DE), high-resolution image analysis with high throughput matrix laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) analysis and large-scale data computing management [15, 16] . In this study, we report comparative proteomic analysis using 2-DE and MALDI-TOF/MS to identify the proteins induced or repressed in response to FSH or LH during preovulatory, periovulatory and postovulatory phases in the ovaries of gonadotropinprimed immature female mice. By comparing proteomic data, we assessed the global changes in protein expression that occur during the mouse ovarian cycle. To verify the protein data, we also examined the protein expression level of selected proteins by Western blot analysis in the mouse ovary.
Materials and Methods

Animals
All mice (ICR) were purchased from Kiwa Experimental Animals (Wakayama, Japan) and maintained in light-controlled and air-conditioned rooms. All animal procedures conformed to the Guidelines of Kinki University for the Care and Use of Laboratory Animals.
Preparation of ovarian tissues
All ovaries were obtained from six immature mice at 3 weeks of age in one experiment. The ovaries from each animal were collected at 0 (non treated as control), 24 or 48 h after an intraperitoneal injection of 5 IU of pregnant mare serum gonadotropin (PMSG; Serotropin, Teikoku Zoki, Tokyo, Japan). In addition, other ovaries were collected from animals with combined treatment by 48 h after an intraperitoneal injection of 5 IU PMSG followed by 5 IU human chorionic gonadtropin (hCG, Puberogen ® , Sankyo, Tokyo, Japan) 10 or 20 h later.
Two-dimensional gel electrophoresis (2-DE)
The ovaries were homogenized on ice in 500 μl lysis buffer composed of 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.05% (v/ v) tri-n-butylphosphine, 0.5% (v/v) immobilized pH gradient (IPG) buffer (GE Healthcare, Little Chalfont, UK), protease inhibitor cocktail and traces of bromophenol blue (BPB). The homogenates were centrifuged at 17,000 g for 10 min at 4 C, and the supernatants were transferred to a new tube two times. Finally, the clear supernatants were collected. The supernatants were transferred to a new tube, and protein concentrations were measured by a modified Bradford-HCL assay using γ-globulin as a standard [17] . All 2-DE procedures were performed according to a previously reported method [18] .The obtained proteins were separated in the first dimension on immobilized pH gradient IPG gels (Immobiline DryStrip, pH 3-11 nonlinear gradient, 18 cm, GE Healthcare).
Samples containing 200 μg of protein were mixed with rehydration solution composed of 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 0.05% (v/v) tri-n-butylphosphine, IPG buffer and traces of BPB. IPG gels were rehydrated for at least 6 h with rehydration solution containing protein samples. First dimensional electrophoresis was performed according to the following manner at 15 C: 1 min of linear gradient from 0 to 500 V, 8 h of constant voltage at 500 V, 1.5 h of linear gradient from 500 to 3500 V and 5.4 h of constant voltage at 3500 V. Strips were then washed with distilled water and equilibrated at room temperature for 15 min in 10 ml of equilibration buffer composed of 6 M urea, 50 mM Tris-HCl (pH 8.0), 30% (v/v) glycerol, 2% (w/v) SDS, 100 mg DTT and traces of BPB before being incubated for 15 min in an equilibration solution consisting of the same components with the exception that the DTT was replaced with 250 mg iodoacetamide. The equilibrated strips was transferred onto the SDS-PAGE gel. Second dimensional electrophoresis was performed on 10% polyacrylamide gel in CoolPhoreStar SDS-PAGE Tetra-200 (Anatech, Tokyo, Japan) with a constant current at 30 mA per gel for 1 h.
Protein visualization and image analysis of 2-DE gels
The gels were fixed with fixation solution containing 10% Methanol and 7% (v/v) acetic acid for 30 min at room temperature and then transferred to new fixation buffer for 30 min. The gels were stained with SYPRO Ruby (Invitrogen, Carlsbad, CA, USA) overnight. The stained gels were washed with 10% EtOH. Gel images were obtained using an AlphaImager (Alpha Innotech, San Leandro, CA, USA) and analyzed using the Progenesis PG220 and TT900 (Nonlinear Dynamics, Newcastle upon Tyne, UK) for spot detection, quantification and comparative analysis.
MALDI sample preparation
For protein digestion, protein spots were collected by hand on a Safe Imager blue light transilluminator (Invitrogen). Gel pieces were washed and incubated twice in destaining solution consisting of 50% (v/v) acetonitrile (ACN) in 50 mM ammonium bicarbonate for 20 min at 37 C three times. The gel pieces were then incubated in 100% (v/v) ACN for 1 min before being dried completely. The obtained proteins were digested with 1.67 μg/ml trypsin (Promega, Southampton, UK) in 25 mM ammonium bicarbonate at 30 C overnight. The digested proteins were purified and concentrated using ZipTip TM μC18 (Millipore, Bedford, MA, USA). The peptides absorbed in the gels were directly eluted onto the MALDI sample plate with 2 mg/ml α-cyano-4-hydroxycinnamic acid (Waters, Milford, MA, USA) in 70% ACN containing 0.1% trifluoroacetic acid.
MALDI-TOF/MS
MS spectrometric analysis of the tryptic digests was performed using a 4700 MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Foster City, CA, USA). MS spectra were measured in the positive-ion reflector mode with a mass range from 700 to 3500. Data were subjected to external calibration with five standard peptides (Sigma, St.Louis, MO, USA). The MS/MS spectra were measured in CID mode. From a single parent MS spectrum, the five most abundant ions were selected for MS/MS analysis. The data were subjected to external calibration using fragment peaks of the human ACTH peptide 18-39 (MH1 2465.1989, Sigma). The raw MS and MS/MS data were used in database searches.
Database searches were performed using the MASCOT search engine (Matrix Science, London, UK, http://www.matrixscience.com/) and the SWISS-PROT and NCBI nonredundant protein sequence databases (http://www.ncbi.nlm.nih.gov/) with a mass tolerance of 0.2 Da. Annotation of protein function was performed using the Panther classification system programs (http:// www.pantherdb.org/)
Western blot analysis
The procedures were performed according to previously reported methods [19] [20] [21] [22] . In brief, the proteins obtained as mentioned above were subjected to SDS-PAGE. The proteins were resolved on 15% running gels and electrophoretically transferred to PVDF membranes (GE Healthcare). The membranes were incubated in block ace (Dainippon Pharmaceutical, Osaka, Japan) for blocking and then incubated with each primary antibody (antiTransferrin . Membranes were incubated with the relevant secondary antibody conjugated to HRP. Immune complexes were developed by enhanced chemiluminescence (ECL, GE Healthcare). The intensity of specific bands on the films was quantified by densitometric analysis using the ImageJ software (NIH, USA). Three independent experiments were performed in this study.
Statistical analysis
For statistical analysis, we used StatView (SAS Institute, Cary, NC, USA) and Microsoft Excel. The quantitative values of the protein expression level in each 2-DE gel were analyzed using Fisher's PLSD test, k-means hierarchical clustering and k-means non-hierarchical clustering. The k-means hierarchical clustering method divides protein spots into groups based on their expression patterns and produces groups of protein spots with a high degree of similarity within each group and a low degree of similarity between groups. K-means non-hierarchical clustering can identify unique classes of protein spots that are up-or down regulated in a time/ treatment-dependent manner. Statistical analyses of the data obtained by Western blot analysis were performed using ANOVA. A value of P<0.05 was considered statistically significant.
Results
Protein profiles of mouse ovarian proteins
In this study, three replicate 2-DE gels from each ovary at 0 h (no PMSG), 24 and 48 h post PMSG, as well as at 10 and 20 h post hCG, were subjected to spot analysis with the Progenesis PG220 and TT900 to construct a reference gel for comparing the protein profiles of mouse ovaries during the preovulatory and ovulatory phases (Fig. 1) . As a consequence, 1028 protein spots were commonly detected on each gel in the 3 to 11 pH range and 10-200 kDa range (Fig. 1A) , and 290 protein spots (126 protein species) were identified by MALDI-TOF/MS (Table 1) . In this case, post?translationally modified proteins were detected as multiple protein spots. Next, using the Panther classification system, we classified 126 proteins into seven categories [23] according to their biological functions: (1) Cell signaling/communication (21%), (2) Metabolism (20%), (3) Gene/protein expression (16%), (4) Cell structure and motility (14%), (5) Cell defense (13%), (6) Cell division (3%), and (7) Unclassified (13%; Fig. 2 ). The ratio of mouse ovarian proteins in the seven groups is consistent with the previously reported results for the human ovary [24] .
Global outlook according to hierarchical clustering and principal component analysis
An unbiased analysis of the protein expression data revealed a transition in the molecular composition of the ovary during the ovarian cycle. The global protein expression changes were compared by k-means hierarchical clustering to determine which were the most similar in terms of global protein expression. As a result, the five time points at 0 (as control), 24 and 48 h after PMSG injection followed by those at 10 and 20 h post-hCG injection were divided into three large groups (Fig. 3A) , one consisting of non-treated ovaries from immature females, another consisting of ovaries treated with PMSG only or PMSG followed by hCG 20 h later, and a final group consisting of ovaries treated with PMSG followed by hCG 10 h later. The three clusters were also supported by principal component analysis (PCA) as another quantitative analysis (Fig. 3B) . The timings of the first major transition from the non-treated imma- ture mouse ovaries to the PMSG-treated ovaries and the second major transition from the PMSG-treated ovaries to the PMSG-hCG treated (10 h) ovaries corresponded well to the major molecular and structural changes that occur during the preovulatory and periovulatory phases, respectively.
Time-course analysis of differentially expressed proteins
Comparison of the ovarian protein expression patterns during the ovarian cycle in immature mice stimulated with exogenous gonadotropins revealed that the expressions of 253 protein spots were significantly changed (P<0.05), 99 protein spots of which were identified by MALDI-TOF/MS. Moreover, we analyzed the 99 protein spots using a k-mean non-hierarchical clustering method and then classified them into eleven clusters (Fig. 3C) .
Clusters 1 (1 protein spot, 1%), 4 (1 protein spot, 1%) and 9 (14 protein spots, 14%) showed a step wise decrease in protein expression level after PMSG stimulation and then an increase during the postovulatory phase, whereas Cluster 2 (65 protein spots, 65%) decreased to its lowest level after PMSG stimulation and then rapidly increased during the postovulatory phase. This first group (Clusters 1, 2, 4 and 9) seems to be mainly involved in a process during the postovulatory phase (for example, early luteinization, etc.). Clusters 3 (1 protein spot, 1%), 6 (1 protein spot, 1%), 7 (1 protein spot, 1%) and 11(1 protein spot, 1%) showed a dramatic increase after PMSG stimulation and then peaked at 10h post hCG injection. This second group (Clusters 3, 6, 7 and 11) appeared to be closely related to ovulation events, representing a single protein species such as a serum albumin precursor. Ten protein spots (10%) in Cluster 5 showed a continuous increase after PMSG stimulation and then peaked at 10 to 20 h post-hCG stimulation and are likely involved in processes during the periovulatory and postovulatory phases. Lastly, Clusters 8 (2 protein spots, 2%) and 10 (3 protein spots, 3%) showed a transient increase during PMSG administration, a decrease from 48 h after PMSG injection and then an increase 20 h after hCG injection. The fourth group (Clusters 8 and 10) may be involved in preovulatory events (for example, folliculogenesis, etc.).
Verification of selected proteins by Western blot analysis
Some of the proteins, heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1), serotransferrin precursor (transferrin) and peroxiredoxin 2, identified by 2-DE and MALDI-TOF/MS (as shown in Table 1 ) were verified by Western blot analysis. As shown in Fig. 4A , the expression levels of the three proteins were differentially changed during the ovarian cycle. The densitometric measurements of these bands from three independent experiments with actin as a control protein are summarized in Fig. 4B . Two of the identified proteins, i.e., a serotransferrin precursor (transferrin) and peroxiredoxin 2, appeared to be upregulated in response to PMSG/hCG, whereas hnRNP A2/B1 was upregulated in response to PMSG.
Discussion
Appreciating the biochemical mechanisms by which gonadotropins directly or indirectly regulate complex biological processes during the mammalian ovarian cycle is important both for basic reproductive biology and for practical applications in animal and human reproductive science. These complex biological processes in the ovary are accompanied by changes in the transcriptional and translational expressions of ovarian genes. Until now, to identify ovarian genes regulated by PMSG and/or hCG injection, a number of previous transcriptomic analyses using DNA microarrays have been performed [10, 25, 26] . Furthermore, a genome wide rat ovarian gene expression database (rOGED) has been constructed (http://web5.mccs.uky.edu/kolab/rogedendo.aspx) [27] . In general, these studies have served to provide a valuable insight into the dynamics of global gene expression changes in the ovary. However, the transcriptomic approach cannot provide any information about translational rate, posttranslational proteolytic processing, modifications such as phosphorylation and glycosylation, or transport via blood vessels. Thus, in this study, we performed a combined experiment using 2-DE and MALDI-TOF/MS analysis to survey protein profiles during the preovulatory, periovulatory and postovulatory phases in the mouse ovary.
In the present study, we constructed a protein expression database during the preovulatory, periovulatory and postovulatory phases in the mouse ovary (Table 1) . In this table, there are a number of known genes that have been reported to be expressed at the RNA and protein level as described below. β-tubulin mRNA is prominently detected during rat follicular development in the early stages of PMSG priming [28] , and 14-3-3 zeta and elongation factor-1 gamma are known to be expressed in bovine matured oocytes [29] . The membrane-binding and communication-related components such as annexin A2 show fluctuations in RNA levels during mouse granulosa cell development and luteinization [30] . The pro- Table 1 .
teomic data list in Table 1 is important information for investigation of function and structural change in the mouse ovary. Unfortunately, in this study, we could not identify mouse vas deferens protein (MVDP), a member of the aldo-keto reductase superfamily, that was previously reported to be an ovarian protein induced by LH [31] , although we did identify aldose reductase (AR), which is known to be involved in clearance of the toxic aldehydes generated by cellular metabolism [32] . MVDP (theoretical pl/molecular weight: 6.77/35988.39) and AR (theoretical pl/molecular weight: 6.71/35732.24) are too similar in pI and MW to be separated by the 2-DE gels (20 × 20 × 0.1cm) used in our study.
To facilitate proteomic comparisons of protein profiles as shown in Table 1 , we performed k-means hierarchical clustering and principal component analysis of protein expression profiles on the basis of the 1028 non-selected protein spots. These clustering algorithms separated the five points (0, 24 and 48 h post PMSG, as well as 10 and 20 h post hCG) into three major clusters (Fig. 3A and 3B ), indicating that the group of proteins expressed in the ovaries collected at 20 h post hCG was classified into the same group as ovaries primed with PMSG alone. This finding suggests that hCG transiently induces dynamic changes in protein expression in gonadotropin-primed ovaries. To our knowledge, this observation is the first suggestion that the transient dynamic changes in ovarian protein expression that are induced by the LH surge result in its morphological changes during the complex process of ovulation. were chosen because the expressions of these proteins have been well examined as described below. Firstly, hnRNP A2/B1 is primarily expressed in oocytes and the nuclei of granulosa cells, suggesting that hnRNP A2/B1 plays a role in mouse oocyte maturation, follicle development or corpus luteum formation [33] . This involvement in the development of follicles and early luteinization was indicated as shown in Fig. 4 , in which hnRNP A2/B1 was significantly increased and then remained constant during the preovulatory phase after PMSG stimulation before being upregulated in the postovulatory phase. Secondly, transferrins, which are iron binding transport proteins, are known to have specific functions in granulosa cells, although little is known of their role in follicle development [34] . Serum transferrin (serotransferrin) may also have a further role in stimulating cell proliferation and suppressing the generation of reactive oxygen species [35] . In addition, peroxiredoxin 2 is a member of the peroxiredoxin family of antioxidant enzymes [36] . Peroxiredoxin proteins also play important roles in maintenance of the intracellular redox balance and protection of cells against oxidative stress due to reactive oxygen radicals in pig oocytes [37] . As shown in Fig. 4 , these proteins were gradually increased by PMSG/hCG stimulation, indicating their involvement in the events of follicular development and ovulation. However, in regard to serum transferrin (serotransferrin), decreased expression was found in ovaries from h10 to h20 by Western blot analysis, while 2-DE did not show the same profiles, as shown in Fig. 3 . This discrepancy in quantification by 2-DE and Western blot analysis could be caused by posttranslational modifications, such as phosphorylation and glycosylation, that change the pI of proteins, resulting in multiple spots not visible in Western analysis.
In conclusion, this is the first report of a comparative proteomic analysis during the ovarian cycle in response to gonadotropins. The proteomic approach provides a global profile of protein expression changes in ovarian tissue after stimulation with gonadotropins. The clustering algorithms identified functionally three protein clusters. These protein expression responses to gonadotropins may represent dramatic transitions from follicular development including oocyte maturation to ovulation and then to transformation of the follicle into a corpus luteum. Protein cluster analysis techniques can be applied in the future to begin to understand biologically relevant reproductive issues, for example, which follicles are selected under common circumstances and which kinds of protein biomarkers are expressed in surviving follicles. Therefore, the proteomics approach is a very useful tool for discovering biomarker protein candidates for the molecular events of ovarian function. However, it is necessary to assess if such diagnostic biomarker candidates of ovarian function discovered in the PMSG and/or hCG-induced model also function in the ovaries of naturally cycling animals.
